Volume 21, Number 4—April 2015
Dispatch
Multidrug-Resistant Salmonella enterica Serotype Typhi, Gulf of Guinea Region, Africa
Table
Location | 1996–1999 | 2000–2004 | 2005–2009 | 2010–2013 |
---|---|---|---|---|
France | ||||
No. isolates studied | 345 | 266 | 627 | 508 |
No. isolates acquired in Africa | 86 | 64 | 155 | 103 |
No. (%) MDR† | 0 | 7 (10.9) | 25 (16.1) | 23 (22.3) |
Country of infection for MDR isolates (no.) | Benin (3), Togo (2), Burkina-Faso (1), Cameroon (1) | Cameroon (7), Côte d’Ivoire (4), Burkina-Faso (3), Angola (2), Congo (1), Mali (1), Benin (1), Nigeria (1), Mauritania (1), Togo (1), Central African Republic (1), Guinea (1), not specified (1) | Côte d’Ivoire (7), Guinea (3), Burkina-Faso (3), Cameroon (2), Congo (1), Central African Republic (1), Niger (1), Mali (1), Nigeria (1), Chad (1), Togo (1), Algeria (1) | |
Yaoundé, Cameroon | ||||
No. isolates studied | ND | 61 | 75 | 49 |
No. (%) MDR | ND | 29 (47.5) | 50 (66.6) | 37 (75.5) |
*MDR, multidrug resistant; ND, not determined.
†For isolates acquired in Africa.
1These authors contributed equally to this article.
2Current affiliation: University of Limoges, Limoges, France.
3Current affiliation: Rockefeller University, New York, New York, USA.
4Current affiliation: Institute Pasteur de Dakar, Dakar, Senegal.
Page created: March 17, 2015
Page updated: March 17, 2015
Page reviewed: March 17, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.